Rare diseases
Investigational molecules
Locations
455 Grand Union Boulevard, 02145-1446, United States
Genetix Biotherapeutics Inc. supports clinical research in inherited blood diseases, with particular attention to sickle-cell disease and beta-thalassaemia. Its studies focus on long-term outcomes in people living with chronic haemoglobinopathies that affect oxygen transport and blood cell production.
The research emphasis includes sustained monitoring of safety and effectiveness in individuals treated for severe inherited anaemias.
Genetix Biotherapeutics Inc. runs clinical trials in conditions such as Sickle cell disease, Adrenoleukodystrophy, Thalassaemia beta, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
